pharma
Pharma & AI
pharma
Trump Taps Heidi Overton, a White House Policy Aide, to Run the FDA
pharma
Insilico Medicine Widens Its AI Drug Discovery Net, From Harvard to Taipei
pharma
Novo Nordisk Bets on Amazon's Cloud to Speed Up Drug Discovery
pharma
AI Moves From Buzzword to Backbone in the Drug Business
pharma
Sword Health Moves to Buy Headspace, State Filing Reveals
pharma
Carterra Says Its Binding Platform Powered an Anthropic Autonomous AI Protein Design Study
pharma
Pharma's Next Big Bet: Can AI Actually Find New Medicines?
pharma
Nvidia-Backed Biotech Says AI Could Make Biology Programmable
pharma
Berry Street and Healthify Merge to Build an AI-Powered Metabolic Care Business
pharma
FDA Hits Pause on Capricor's Duchenne Cell Therapy — Again
pharma
FDA Halts Regenxbio Gene Therapy Trial After Spinal Masses Found in Five Patients
pharma
Bausch + Lomb's Dry Eye Drop Missed Its Phase 2 Goal. The CEO Calls It a Win.
pharma
Generative AI Is Reshaping the Hunt for New Drugs
pharma
A Seoul Hospital Is Pointing Quantum Computers at Your Heart
pharma
Before AI Can Cure ALS, Someone Has to Build the Data
pharma
Two Biotech Heavyweights Sign On to China's Haisco
pharma
FDA Clears Jazz's Ziihera for Newly Diagnosed Gastric Cancer Patients
pharma
After a Funding Slump, Women's Health Startups Bet on AI for a Comeback
pharma
OmicsBank Lands $2.25M to Funnel Overseas Patient Data Into AI Drug Discovery
pharma
Bristol Myers Pulls the Plug on Cellares, Forcing a Restructuring
pharma
AI Is Rewriting Drug Discovery — But Its Biggest Bottleneck Isn't the Algorithm
pharma
AI Is Now Designing Viruses to Kill Drug-Resistant E. coli
pharma
AI Enters the Psychiatrist's Classroom — and the Field Is Weighing the Trade-Offs
pharma
FDA Clears Ultragenyx's Genglycos, the Company's First Gene Therapy
pharma
Moderna and Merck's Personalized Cancer Vaccine Clears Its First Phase 3 Test
pharma
FDA Clears Regeneron's Pasatru, a First Rival in the Disease That Turns Muscle to Bone
pharma
AI Drug Discovery Stocks Draw Investor Attention as Pharma Rethinks R&D
pharma
RFK Jr. Opens the Door to Softer U.S. Vaccine Recommendations
pharma
India Wants to Be the World's Lab, Not Just Its Pharmacy — and AI Is the Plan
pharma
AI Comes for the Skin Cream: Inside Pharma's Formulation Shake-Up
pharma
The Obesity Drug Race Moves Past Ozempic — and Into Chemistry Class
pharma
AI Is Racing Through Drug Discovery. The Clinic Is Where It Gets Tested.
pharma
QuantHealth Banks $45M to Simulate Clinical Trials Before They Happen
pharma
Newer AI Models Still Carry Old Medical Biases, Flinders Researchers Warn
pharma
Healthcare AI Has the Technology. Does It Still Have Public Permission?
pharma
AI Moves Into the Exam Room: Fetal Ultrasound and Patient Q&A Under the Microscope
pharma
Experts Say AI Could Move Medicine From Diagnosing Illness to Predicting It
pharma
Third Time's the Charm: Replimune Wins FDA Nod for Melanoma Drug After Two Rejections
pharma